Research | tPBM Improves Cognitive Performance in Healthy Brains
Research show t-PBM has a significant, beneficial effect on cognitive performance in young, healthy adults. Nine studies were examined, of which seven studies were performed on young, health subjects ages 17-24 and two were conducted on older normal subjects ages 49 and up.
Research | tPBM for the Treatment of Major Depressive Disorder, Elated 2
This paper reports the results from the Elated-2 Pilot Trial. The study is comprised of 21 adult MDD patients age 18 to 65, who underwent twice weekly transcranial photobiomodulation (t-BPM) sessions for 8 weeks. The study finds subjects receiving t-PBM with NIR light showed greater improvement than the sham group that did not receive any light therapy.
Research | tPBM for the Management of Depression: Current Perspectives
Current treatments for depression have significant efficacy and side effect burden. This paper provides a comprehensive overview of years of research on a novel, safe approach called transcranial photobiomodulation (t-PBM) as a device-based treatment that is efficacious, well-tolerated and easy to use.
